Skip to content
10-Q

Quarterly Report

ZIVO BIOSCIENCE, INC. ZIVO

0001654954-24-010644

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 9, 2024 3.37M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $2.87M
Current Liabilities Q2 2024 · Dec 31, 2023 $2.76M
Total Liabilities Q2 2024 · Jun 30, 2024 $2.87M
Total Liabilities Q2 2024 · Dec 31, 2023 $2.76M
Current Assets Q2 2024 · Jun 30, 2024 $495.13K
Current Assets Q2 2024 · Dec 31, 2023 $425.38K
Total Assets Q2 2024 · Jun 30, 2024 $575.59K
Total Assets Q2 2024 · Dec 31, 2023 $555.72K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$3.11M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$3.14M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$1.74M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$10.62K
Sga Expense Q2 2024 · Jun 30, 2023 $1.39M
Sga Expense Q2 2024 · Jun 30, 2023 $2.95M
Rd Expense Q2 2024 · Jun 30, 2023 $442.11K
Rd Expense Q2 2024 · Jun 30, 2023 $843.91K
Net Income Q2 2024 · Jun 30, 2023 −$2.07M
Net Income Q2 2024 · Jun 30, 2023 −$4.04M
Operating Income Q2 2024 · Jun 30, 2023 −$1.82M
Operating Income Q2 2024 · Jun 30, 2023 −$3.79M
Gross Profit Q2 2024 · Jun 30, 2023 $3.35K
Gross Profit Q2 2024 · Jun 30, 2023 $3.35K
Revenue Q2 2024 · Jun 30, 2023 $4.05K
Revenue Q2 2024 · Jun 30, 2023 $4.05K